|
SBH
Sally Beauty Holdings, Inc.
SBH · Q4 FY2025
|
Q4 FY2025 |
|
SBH Q4 FY2025 transcript
|
|
RNXT
RenovoRx, Inc.
RNXT · Q3 FY2025
|
Q3 FY2025 |
|
RNXT Q3 FY2025 transcript
|
|
HYPD
Hyperion Defi, Inc.
HYPD · Q3 FY2025
|
Q3 FY2025 |
|
HYPD Q3 FY2025 transcript
|
|
FLNT
Fluent, Inc.
FLNT · Q3 FY2025
|
Q3 FY2025 |
|
FLNT Q3 FY2025 transcript
|
|
PLX
Protalix BioTherapeutics, Inc.
PLX · Q3 FY2025
|
Q3 FY2025 |
|
PLX Q3 FY2025 transcript
|
|
EVLV
Evolv Technologies Holdings, Inc.
EVLV · Q3 FY2025
|
Q3 FY2025 |
|
EVLV Q3 FY2025 transcript
|
|
STUB
StubHub Holdings, Inc.
STUB · Q3 FY2025
|
Q3 FY2025 |
|
STUB Q3 FY2025 transcript
|
|
AMAT
Applied Materials Inc /De
AMAT · Q4 FY2025
|
Q4 FY2025 |
|
AMAT Q4 FY2025 transcript
|
|
NXPL
NextPlat Corp
NXPL · Q3 FY2025
|
Q3 FY2025 |
|
NXPL Q3 FY2025 transcript
|
|
ZSPC
zSpace, Inc.
ZSPC · Q3 FY2025
|
Q3 FY2025 |
|
ZSPC Q3 FY2025 transcript
|
|
BWEN
Broadwind, Inc.
BWEN · Q3 FY2025
|
Q3 FY2025 |
|
BWEN Q3 FY2025 transcript
|
|
DIS
Walt Disney Co
DIS · Q4 FY2025
|
Q4 FY2025 |
|
DIS Q4 FY2025 transcript
|
|
GOVX
GeoVax Labs, Inc.
GOVX · Q3 FY2025
|
Q3 FY2025 |
|
GOVX Q3 FY2025 transcript
|
|
CBUS
Cibus, Inc.
CBUS · Q3 FY2025
|
Q3 FY2025 |
|
CBUS Q3 FY2025 transcript
|
|
BFRI
Biofrontera Inc.
BFRI · Q3 FY2025
|
Q3 FY2025 |
|
BFRI Q3 FY2025 transcript
|
|
TELA
TELA Bio, Inc.
TELA · Q3 FY2025
|
Q3 FY2025 |
|
TELA Q3 FY2025 transcript
|
|
GRSD
GRANDSTAND Ltd
GRSD · Q3 FY2025
|
Q3 FY2025 |
|
GRSD Q3 FY2025 transcript
|
|
ONDS
Ondas Inc.
ONDS · Q3 FY2025
|
Q3 FY2025 |
|
ONDS Q3 FY2025 transcript
|
|
TPCS
Techprecision Corp
TPCS · Q2 FY2026
|
Q2 FY2026 |
|
TPCS Q2 FY2026 transcript
|
|
FTLF
Fitlife Brands, Inc.
FTLF · Q3 FY2025
|
Q3 FY2025 |
|
FTLF Q3 FY2025 transcript
|
|
ASFH
Asiafin Holdings Corp.
ASFH · Q3 FY2025
|
Q3 FY2025 |
|
ASFH Q3 FY2025 transcript
|
|
JCAP
Jefferson Capital, Inc. / DE
JCAP · Q3 FY2025
|
Q3 FY2025 |
|
JCAP Q3 FY2025 transcript
|
|
JG
Aurora Mobile Ltd
JG · Q3 FY2025
|
Q3 FY2025 |
|
JG Q3 FY2025 transcript
|
|
TRVI
Trevi Therapeutics, Inc.
TRVI · Q3 FY2025
|
Q3 FY2025 |
|
TRVI Q3 FY2025 transcript
|